23 Figure 1. Percentage of patients with PCR-positive nasopharyngeal samples from inclusion to day6 post-inclusion in COVID-19 patients treated with hydroxychloroquine and in COVID-19 control patients.
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19 Page 22 Page 24